Phenylphosphine Gold Drug Auranofin Intermediate
Auranofin intermediate featuring aromatic phosphine coordinated with gold, used in rheumatoid arthritis treatment. Falls under HTS 2931.90.22.00 as an aromatic organo-inorganic drug with phosphorus and metal directly linked to aromatic carbon.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If gold salt without organic phosphine ligand
Inorganic gold salts lacking organo-inorganic carbon linkage classify in Chapter 28.
If tetrazoles or derivatives predominate
Specific organo-inorganic functional groups have dedicated headings taking precedence.
If finished oral dosage form for retail
Completed gold arthritis medications in dosage forms classify as medicaments in Chapter 30.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Provide coordination chemistry analysis showing metal-carbon linkages through Chapter 29 note 3(C)(3)
• Include DEA/FDA precursor documentation if used in controlled substance synthesis
• Label with GHS hazard symbols for organometallic toxicity during customs clearance
Related Products under HTS 2931.90.22.00
Aromatic Arsenic Drug Triphenylarsine Oxide
Triphenylarsine oxide is an aromatic organo-arsenic compound used as an intermediate in pharmaceutical synthesis for anti-cancer drugs. It falls under HTS 2931.90.22.00 as an aromatic organo-inorganic drug containing arsenic directly linked to carbon, meeting Chapter 29 requirements for chemically defined compounds.
4-Dimethylaminophenylarsine Drug Intermediate
This aromatic organo-arsenic compound serves as a key intermediate in synthesizing anti-parasitic drugs. Classified under HTS 2931.90.22.00 due to its aromatic structure with arsenic directly bonded to carbon and designated pharmaceutical application.
Aromatic Silane Platinum Anti-Cancer Drug
Platinum-based chemotherapy agent with aromatic silane ligands, used in cancer treatment protocols. HTS 2931.90.22.00 classification applies to this aromatic organo-inorganic compound containing silicon and platinum linked to carbon.
Organotin Aromatic Drug Candidate
Aromatic organotin compound under development for anti-microbial pharmaceutical applications. Classified in HTS 2931.90.22.00 as an aromatic organo-inorganic drug with tin directly bonded to aromatic carbon.
Ferrocene Aromatic Drug Derivative
Ferrocene-based aromatic metallocene used in anti-cancer drug development with iron-carbon sandwich structure. HTS 2931.90.22.00 covers this aromatic organo-inorganic pharmaceutical as metal is linked through carbon atoms.
Aryl Boronic Acid Platinum Drug Complex
Platinum anti-tumor agent featuring aromatic boronic acid ligands for targeted cancer therapy. Falls under HTS 2931.90.22.00 as aromatic organo-inorganic containing boron and platinum linked to carbon.